Bernard Thorens
9Patents
5h-index
7Co-inventors
52Inventor score
Filing activity: Nov 24, 1993 → Oct 1, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5670360A | Mammalian receptors for glucagon-like-peptide-1 (GLP-1), corresponding DNA and recombinant expression systems, and screening assays for GLP-1 agonists and enhancers | Physics | 54 | Expired |
| US6051689A | Receptor for the glucagon-like-peptide (GLP-1) | Physics | 49 | Expired |
| US5846747A | Method for detecting glucagon-like peptide-1 antagonists and agonists | Physics | 48 | Expired |
| US6451601B1 | Transiently immortalized cells for use in gene therapy | Chemistry; Metallurgy | 23 | Expired |
| US6358739B1 | Transiently immortalized cells | Chemistry; Metallurgy | 22 | Expired |
| US8852939B2 | Use of Vgll3 activity modulator for the modulation of adipogenesis | Physics | 2 | Active |
| US8841270B2 | Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis | Physics | 0 | Active |
| US8759311B2 | Use of siRNA targetting SIPA1L1 for the reduction of adipogenesis | Chemistry; Metallurgy | 0 | Active |
| US6074875A | Materials and methods relating to the regulation of polypeptide production in cells | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.